Thus, our results validate PLA2 toxins with membrane-disturbing activities as a source of promising dual-target therapeutic peptides that might be useful in the development of new treatments for cancer and bacterial infections, including those caused by MDR strains. This evidence concerns the gene PLA2G2A and cancer.